AN ADJUVANT FORMULATION CONTAINING TOLL-LIKE RECEPTOR 7 AGONIST STIMULATES PROTECTION AGAINST MORBIDITY AND MORTALITY DUE TO ANAPLASMA MARGINALE IN A HIGHLY ENDEMIC REGION OF WEST AFRICA.

Efficient cattle production and provision of animal-sourced foods in much of Africa is constrained by vector-borne bacterial and protozoal diseases.Effective vaccines are not currently available for most of these infections resulting in a continuous disease burden that limits genetic improvement.We tested whether stimulation of innate immunity usin

Modern neurosurgical equipment and techniques, neuroendoscopy in particular, allow performing complex operations even in the deep and narrow anatomical structures of the brain without injuring vessels or soft tissue Braces and consequently lowers risk of postoperative complications.The surgical treatment includes classical open microsurgical and mi

Glioblastoma (GBM) is a highly aggressive and lethal brain cancer with a median survival of less than two years after diagnosis.Hallmarks of GBM tumors include soaring proliferative indices, high levels Flywheel Housing of angiogenesis, diffuse invasion into normal brain parenchyma, resistance toward therapy-induced apoptosis, and pseudopallisading